Reading the annual reports…

First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.

Resolute Holdings Management, Inc. (RHLD) financial health, profit and balance sheet · Scorvest

RHLD · NYSE · United States · Finance Services

Resolute Holdings Management, Inc.

New York, NY · Fiscal year ends in December · Figures in USD

+ Add to watchlist Compare

In shortResolute Holdings Management, Inc. is loss-making.

Financial health

Weak

Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.

How is this score calculated? →

Profitability38

Operating marginShare of each sale left after running the business, before interest and tax.	31.0%	100/100
Net marginShare of each sale left as profit after every cost, interest and tax.	-1.3%	15/100
Return on equityProfit earned on the money shareholders put in. Above 15% is strong.	-207.5%	0/100

Weight in the score: 25%

Balance sheet0
Equity / assets 2.0% 0/100
Weight in the score: 25%

Equity / assets	2.0%	0/100

Cash generation–

Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt.	41.0%	n/a
Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy.	–	n/a
Years with positive free cash flow (last 5)	2 of 2	n/a

Weight in the score: 20%

Stability67
Profitable years (last 5) 0 of 2 0/100
Years of revenue decline (last 5) 0 of 1 100/100
Revenue growth volatility – n/a
Operating margin volatility 0.6% 100/100
Weight in the score: 20%
Growth–
Revenue growth, 3-year average – n/a
EPS growth, 3-year average – n/a
Weight in the score: 10%

Profitable years (last 5)	0 of 2	0/100
Years of revenue decline (last 5)	0 of 1	100/100
Revenue growth volatility	–	n/a
Operating margin volatility	0.6%	100/100

Revenue growth, 3-year average	–	n/a
EPS growth, 3-year average	–	n/a

Fiscal year 2025 · change vs prior year

Revenue: $462.1M; ▲ 9.9%
Net income: −$5.9M; ▼ 153.8%
Total assets: $332.7M; ▲ 64.9%
Operating margin: 31.0%; +0.9 pts
Cash & investments: $205.5M; –
Total debt: $184.1M; ▼ 5.9%
Diluted EPS: −$0.69; ▼ 155.6%
Return on equity: −207.5%; –

Trends

Annual figures as reported. Hover a bar or point for the exact value.

Revenue and net income

RevenueNet income

Margins

OperatingNet

Statements

The last 2 fiscal years from the company's annual reports.

USD millions; negative values in parentheses.

Fiscal year	FY24	FY25
Revenue	421	462
Cost of revenue	201	202
Gross profit	219	260
Research & development	7.4	6.6
Selling, general & admin	93	117
Operating income	127	143
Interest expense	20	13
Pre-tax income	110	135
Income tax	(0)	0.9
Net income	(2.3)	(5.9)
Diluted EPS	−$0.27	−$0.69
Diluted shares (millions)	8.5	8.5

🔒 Export to Excel · Investor plan

Risk checks

Altman Z'' score

Not computed: the model does not apply to banks and insurers.

Piotroski F-score

6/9

Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.

Positive net income: failed
Positive operating cash flow: passed
Return on assets improved: failed
Cash flow exceeds net income: passed
Long-term debt ratio fell: passed
Current ratio improved: passed
No share dilution: passed
Gross margin improved: passed
Asset turnover improved: failed

Sources

10-QPeriod ending Jun 30, 2026Filed Aug 6, 2026Open the report ↗
10-QPeriod ending Mar 31, 2026Filed May 7, 2026Open the report ↗
10-KPeriod ending Dec 31, 2025Filed Mar 12, 2026Open the report ↗
10-QPeriod ending Sep 30, 2025Filed Nov 3, 2025Open the report ↗
10-QPeriod ending Jun 30, 2025Filed Aug 7, 2025Open the report ↗
10-QPeriod ending Mar 31, 2025Filed May 12, 2025Open the report ↗
10-KPeriod ending Dec 31, 2024Filed Mar 31, 2025Open the report ↗

All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice.